Meaghan Wall

3.7k total citations
57 papers, 1.6k citations indexed

About

Meaghan Wall is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Meaghan Wall has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Hematology and 17 papers in Genetics. Recurrent topics in Meaghan Wall's work include Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Meaghan Wall is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). Meaghan Wall collaborates with scholars based in Australia, United States and United Kingdom. Meaghan Wall's co-authors include Grant A. McArthur, Ross D. Hannan, Gretchen Poortinga, Richard B. Pearson, Katherine M. Hannan, Carl R. Walkley, Lynda J. Campbell, A.L. Muggleton-Harris, Louise E. Purton and John F. Seymour and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Meaghan Wall

52 papers receiving 1.6k citations

Peers

Countries citing papers authored by Meaghan Wall

Since Specialization

Citations

This map shows the geographic impact of Meaghan Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meaghan Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meaghan Wall more than expected).

Fields of papers citing papers by Meaghan Wall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meaghan Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meaghan Wall. The network helps show where Meaghan Wall may publish in the future.

Co-authorship network of co-authors of Meaghan Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Meaghan Wall. A scholar is included among the top collaborators of Meaghan Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meaghan Wall. Meaghan Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The PreGen Research Program: Implementing Prenatal Genomic Testing in Australia—A Commentary 2025 ·Australian and New Zealand Journal of Obstetrics and Gynaecology ·Sarah S. Long, Deborah Schofield, (unknown), (unknown), (unknown), (unknown), (unknown), Alyssa M. Wilson, Jon Hyett, Claire E. Wakefield, Lauren Kelada, Hamish S. Scott, Sebastian Lunke, Meaghan Wall, Michael F. Buckley, (unknown), George McGillivray, Tony Roscioli	0
2	Epigenomic newborn screening for conditions with intellectual disability and autistic features in Australian newborns 2024 ·Epigenomics ·Mohammed Abdullah Alshawsh, Melissa Wake, Jozef Gécz, Mark Corbett, Richard Saffery, James Pitt, Ronda F. Greaves, Katrina Williams, Michael Field, Jeanie L.Y. Cheong, Minh Bui, S. K. Arora, Simon Sadedin, Sebastian Lunke, Meaghan Wall, David J. Amor, David E. Godler	2
3	Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns? 2023 ·Pharmacogenomics and Personalized Medicine ·Danya F. Vears, Julian Savulescu, John Christodoulou, Meaghan Wall, Ainsley J. Newson	12
4	Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies 2023 ·Cellular and Molecular Life Sciences ·Tom C. Karagiannis, Meaghan Wall, Katherine Ververis, Eleni Pitsillou, Stephanie M. Tortorella, P.A. Wood, Haloom Rafehi, Ishant Khurana, Scott Maxwell, Andrew Hung, Jitraporn Vongsvivut, Assam El‐Osta	8
5	Newborn bloodspot screening in the time of COVID-19 2021 ·Genetics in Medicine ·Ronda F. Greaves, James Pitt, (unknown), Meaghan Wall, John Christodoulou	8
6	Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months 2020 ·Blood Advances ·Thomas E. Lew, Mary Ann Anderson, Victor S. Lin, Sasanka M. Handunnetti, Neil Came, Piers Blombery, David Westerman, Meaghan Wall, Constantine S. Tam, Andrew W. Roberts, John F. Seymour	31
7	Cep55 overexpression promotes genomic instability and tumorigenesis in mice 2020 ·Communications Biology ·Debottam Sinha, Purba Nag, Devathri Nanayakkara, Pascal H. G. Duijf, Andrew Burgess, Prahlad V. Raninga, Veronique A. J. Smits, Amanda L. Bain, (unknown), Meaghan Wall, John Finnie, Murugan Kalimutho, Kum Kum Khanna	24
8	Hemopoietic Cell Kinase amplification with Protein Tyrosine Phosphatase Receptor T depletion leads to polycythemia, aberrant marrow erythoid maturation, and splenomegaly 2019 ·Scientific Reports ·Matthew Ku, Ruth N. MacKinnon, Meaghan Wall, Nisha Narayan, Carl R. Walkley, Heung‐Chin Cheng, Lynda J. Campbell, Louise E. Purton, Harshal Nandurkar	4
9	The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion 2016 ·Cytogenetic and Genome Research ·Ruth N. MacKinnon, Hendrika M. Duivenvoorden, Lynda J. Campbell, Meaghan Wall	2
10	The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis 2014 ·Journal of Clinical Investigation ·Monique Smeets, (unknown), Meaghan Wall, Julie Quach, Alistair M. Chalk, Andrew J. Deans, Jörg Heierhorst, Louise E. Purton, David J. Izon, Carl R. Walkley	34
11	Underestimation of Myelodysplastic Syndrome Incidence by Cancer Registries 2014 ·Cancer ·Zoe McQuilten, Erica M. Wood, Mark N. Polizzotto, Lynda J. Campbell, Meaghan Wall, David J. Curtis, Helen Farrugia, John J. McNeil, Vijaya Sundararajan	1
12	The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease 2014 ·Haematologica ·Sofie Singbrant, Meaghan Wall, Jennifer L. Moody, Göran Karlsson, Alistair M. Chalk, Brian Liddicoat, (unknown), Carl R. Walkley, Stefan Karlsson	17
13	Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer 2013 ·Clinical Cancer Research ·Dariush Etemadmoghadam, George Au‐Yeung, Meaghan Wall, Thomas J. Mitchell, Maya Kansara, Elizabeth Loehrer, (unknown), Joshy George, Sarah Ftouni, Barbara A. Weir, Scott L. Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C. Hahn, Paul Waring, Gad Getz, Carleen Cullinane, Lynda J. Campbell, David D.L. Bowtell	90
14	Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA 2013 ·Bone ·Anthony J. Mutsaers, (unknown), Emma K. Baker, (unknown), Alistair M. Chalk, Meaghan Wall, (unknown), P.W.M. Ho, John Slavin, (unknown), T. John Martin, Louise E. Purton, Ross A. Dickins, Carl R. Walkley	61
15	The mTORC1 Inhibitor Everolimus Prevents and Treats Eμ- Myc Lymphoma by Restoring Oncogene-Induced Senescence 2012 ·Cancer Discovery ·Meaghan Wall, Gretchen Poortinga, Kym L. Stanley, Ralph K. Lindemann, Michael Bots, Christopher J. Chan, Megan J. Bywater, Kathryn M. Kinross, Megan V. Astle, Kelly Waldeck, Katherine M. Hannan, Jake Shortt, Mark J. Smyth, Scott W. Lowe, Ross D. Hannan, Richard B. Pearson, Ricky W. Johnstone, Grant A. McArthur	52
16	A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes 2011 ·Cancer Genetics ·Ruth N. MacKinnon, George Kannourakis, Meaghan Wall, Lynda J. Campbell	22
17	c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation 2010 ·Nucleic Acids Research ·Gretchen Poortinga, Meaghan Wall, Elaine Sanij, (unknown), Jason Ellul, Daniel V. Brown, Timothy P. Holloway, Ross D. Hannan, Grant A. McArthur	76
18	The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion 2010 ·Genes Chromosomes and Cancer ·Ruth N. MacKinnon, Carly Selan, Meaghan Wall, Elizabeth Baker, Harshal Nandurkar, Lynda J. Campbell	39
19	MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation 2004 ·The EMBO Journal ·Gretchen Poortinga, Katherine M. Hannan, (unknown), Carl R. Walkley, Anna Jenkins, Kerith Sharkey, Meaghan Wall, Yves Brandenburger, Manuela Palatsides, Richard B. Pearson, Grant A. McArthur, Ross D. Hannan	147
20	A retrospective analysis of the in-vitro development of ‘spare’ human in-vitro fertilization preimplantation embryos using ‘in-house’ prepared medium and ‘Medi-Cult’ commercial medium 1995 ·Human Reproduction ·A.L. Muggleton-Harris, (unknown), Meaghan Wall	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact